Get started
Author

Ola Ghoneim

Observed names: O A Ghoneim, Ola A. Ghoneim, Ola A. M. Ghoneim
ORCID: 0000-0002-2820-3972
Observed ORCID: 0000-0002-2820-3972
OpenAlex ID: A5034724912
Quality of life of caregivers of children with autism in Qatar
2012 · Nadir Kheir, Ola Ghoneim, et al. · Autism · 117
Microneedle-Based Vaccine Delivery: Review of an Emerging Technology
2022 · Ihab Mansoor, Heba A. Eassa, et al. · AAPS PharmSciTech · 78
PDF
Quinazoline Based HDAC Dual Inhibitors as Potential Anti-Cancer Agents
2022 · Jyothi Dhuguru, Ola A. Ghoneim · Molecules · 57
PDF
Free-fatty acid receptor-4 (FFA4) modulates ROS generation and COX-2 expression via the C-terminal β-arrestin phosphosensor in Raw 264.7 macrophages
2017 · Ameneh Cheshmehkani, Ilya S. Senatorov, et al. · Biochemical Pharmacology · 38
Nucleophilic Aromatic Substitution—Addition and Identification of an Amine
2017 · Steven W. Goldstein, Ashley Bill, et al. · Journal of Chemical Education · 21
Mobile-Based Augmented Reality Application in Pharmacy Schools Implemented in Pharmaceutical Compounding Laboratories: Students’ Benefits and Reception
2022 · Mohamed Ismail Nounou, Heba A. Eassa, et al. · Pharmacy · 17
PDF
Novel Piperazino-Enaminones Suppress Pro-Inflammatory Cytokines and Inhibit Chemokine Receptor CCR2
2016 · Doreen E. Szollosi, Ola A. M. Ghoneim, et al. · Inflammation · 17
Developing pharmacy student empathy using mock HIV antiretroviral therapy regimens: A learning activity
2016 · Doreen E. Wesche-Szollosi, Ola Ghoneim, et al. · Currents in Pharmacy Teaching and Learning · 8
Novel Piperazino-Enaminones Decrease Pro-inflammatory Cytokines Following Hemarthrosis in a Hemophilia Mouse Model
2019 · Chen Zhong, Doreen Szollosi, et al. · Inflammation · 4
Implementation of an elective course to introduce pharmaceutical sciences research
2016 · Ola Ghoneim, Richard H. Alper, et al. · Currents in Pharmacy Teaching and Learning · 4
Synthesis of certain new 2,4,5(6) trisubstituted-1,2,4-triazolo[1,5-alpha]pyrimidines as potential antihypertensive agents.
1999 · S M Bayomi, A M Abdelal, et al. · PubMed · 1
One size does not fit all: Pharmacists’ perspectives on disparities in quality care provided to adult patients on the Autism Spectrum Disorder
2022 · Ola Ghoneim, Heba Eassa, et al. · Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences
PDF
The novel piperazino-enaminone JOAB-40 reduced colitis severity in mice via inhibition tumor necrosis factor-α and interleukin-1β
2021 · Maitham A. Khajah, Sanaa Hawai, et al. · Biomedicine & Pharmacotherapy
PDF
Novel compound JOAB-40 decreases inflammation in vitro and colitis severity in vivo by using the murine Dextran Sulfate Sodium (DSS) model
2020 · Doreen E Szollosi, Maitham Khajah, et al. · The Journal of Immunology
Anti-inflammatory activity of the piperazino-enaminone JODI-19 in vitro and in vivo
2018 · Doreen Szollosi, Junjiang Sun, et al. · The Journal of Immunology
Assessment of the dual mechanism of inflammatory inhibition by the novel JODI series of compounds
2017 · Doreen Szollosi, Mohammed Manzoor, et al. · The Journal of Immunology
Computer-Aided Design and Synthesis of N-aryl and Heteroarylpiperazine Derivatives as Dual Serotonergic Antagonists for Autism Treatment
2016 · Raed Shalaby, Ola Ghoneim, et al. · Qatar Foundation Annual Research Conference (ARC)
PDF
Works count: 17
Citation count: 362
H-index: 8
I10-index: 7
Year
Topic
Type